AMCAP
Live / Applied — Non-final action mailed (as of 05 Feb 2026)
What this means for you
Not registered yet, but its 04 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79434997
- Mark type
- Stylized text
- Filed
- 04 Aug 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical drugs; medicines; chemical preparations for pharmaceutical purposes; biological preparations for medical purposes; chemico-pharmaceutical preparations; biological reagents for medical purposes; vaccines; nucleic acid-based pharmaceutical and veterinary products; food and dietary substances for medical or veterinary use; therapeutic antibodies; dietary supplements and preparations; pharmaceutical and natural medicines; nucleic acid-based preparations; cell-based preparations; tissue-based preparations; biological preparations; biological preparations for medical and pharmaceutical use; diagnostic preparations; engineered biological tissues for medical purposes; sanitary preparations for medical purposes; advanced therapy medicinal products; personalized medicine products; regenerative medicine products; somatic cell therapy products; gene therapy products; recombinant human protein being biochemical preparations and nucleic acid sequences for medical use.
- Class 042 — Scientific and technological services: Research and development of vaccines and nucleic acid-based medicines; scientific and technological services; research services in the medical and pharmaceutical fields; development of pharmaceutical preparations and medicines; development of pharmaceutical reagents and medicines; providing information and data relating to medical and veterinary research and development; medical laboratories; design and development of hardware and software; research and development in the biochemical and nucleic acid fields; research and development services in the field of microorganisms and cells; research and development services in the field of diagnostic preparations; research and development in the pharmaceutical and biotechnological sector; research and development services for the pharmaceutical industry; scientific research in the biological field; research on medicines; research on reagents; medical research laboratory services; research services for the development of new pharmaceutical products and advanced therapies; development of biological drugs and advanced therapies; biological and chemical analysis in the medical and pharmaceutical fields.
Owner
- ANEMOCYTE S.R.L., IT
Prosecution history
- 26 Feb 2026 — REFUSAL PROCESSED BY IB
- 06 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 05 Feb 2026 — REFUSAL PROCESSED BY MPU
- 10 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 09 Jan 2026 — NON-FINAL ACTION WRITTEN
- 17 Dec 2025 — ASSIGNED TO EXAMINER
- 21 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Oct 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB